These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 19414243)
1. Polyelectrolyte complex of chondroitin sulfate and peptide with lower pI value in poly(lactide-co-glycolide) microsphere for stability and controlled release. Park W; Na K Colloids Surf B Biointerfaces; 2009 Sep; 72(2):193-200. PubMed ID: 19414243 [TBL] [Abstract][Full Text] [Related]
2. Protein complexed with chondroitin sulfate in poly(lactide-co-glycolide) microspheres. Lee ES; Park KH; Kang D; Park IS; Min HY; Lee DH; Kim S; Kim JH; Na K Biomaterials; 2007 Jun; 28(17):2754-62. PubMed ID: 17337049 [TBL] [Abstract][Full Text] [Related]
3. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres. Kim JH; Taluja A; Knutson K; Han Bae Y J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769 [TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying. Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422 [TBL] [Abstract][Full Text] [Related]
5. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
6. Multi-arm histidine copolymer for controlled release of insulin from poly(lactide-co-glycolide) microsphere. Park W; Kim D; Kang HC; Bae YH; Na K Biomaterials; 2012 Dec; 33(34):8848-57. PubMed ID: 22959184 [TBL] [Abstract][Full Text] [Related]
7. A sulfate polysaccharide/TNF-related apoptosis-inducing ligand (TRAIL) complex for the long-term delivery of TRAIL in poly(lactic-co-glycolic acid) (PLGA) microspheres. Kim H; Jeong D; Kang HE; Lee KC; Na K J Pharm Pharmacol; 2013 Jan; 65(1):11-21. PubMed ID: 23215683 [TBL] [Abstract][Full Text] [Related]
8. How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-beta-cyclodextrin system. De Rosa G; Larobina D; Immacolata La Rotonda M; Musto P; Quaglia F; Ungaro F J Control Release; 2005 Jan; 102(1):71-83. PubMed ID: 15653135 [TBL] [Abstract][Full Text] [Related]
9. Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Kawashima Y; Yamamoto H; Takeuchi H; Hino T; Niwa T Eur J Pharm Biopharm; 1998 Jan; 45(1):41-8. PubMed ID: 9689534 [TBL] [Abstract][Full Text] [Related]
10. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres. Janoria KG; Mitra AK Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204 [TBL] [Abstract][Full Text] [Related]
11. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
12. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265 [TBL] [Abstract][Full Text] [Related]
13. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions. Murty SB; Goodman J; Thanoo BC; DeLuca PP AAPS PharmSciTech; 2003 Oct; 4(4):E50. PubMed ID: 15198545 [TBL] [Abstract][Full Text] [Related]
14. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. Bae SE; Son JS; Park K; Han DK J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089 [TBL] [Abstract][Full Text] [Related]
15. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery. Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101 [TBL] [Abstract][Full Text] [Related]
16. The initial release of cisplatin from poly(lactide-co-glycolide) microspheres. Lee YS; Lowe JP; Gilby E; Perera S; Rigby SP Int J Pharm; 2010 Jan; 383(1-2):244-54. PubMed ID: 19766179 [TBL] [Abstract][Full Text] [Related]
17. Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying. Quaglia F; De Rosa G; Granata E; Ungaro F; Fattal E; Immacolata La Rotonda M J Control Release; 2003 Jan; 86(2-3):267-78. PubMed ID: 12526823 [TBL] [Abstract][Full Text] [Related]
18. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. Liu J; Meisner D; Kwong E; Wu XY; Johnston MR Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581 [TBL] [Abstract][Full Text] [Related]
19. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B. Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638 [TBL] [Abstract][Full Text] [Related]
20. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures. Virto MR; Elorza B; Torrado S; Elorza Mde L; Frutos G Biomaterials; 2007 Feb; 28(5):877-85. PubMed ID: 17064761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]